Hjem › Hæmofili B › New York
Hæmofili B kliniske forsøg i New York
5 studier for Hæmofili B søger deltagere på steder i New York.
Officiel studietekst (engelsk)
Safety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec in Patients With Hemophilia A or B Respectively
- Cornell University||Joan & Sanford I. Weill Medical College, New York
- Weill Cornell Medical College-New York Presbyterian Hospital, New York
RekruttererFase 3
Alder 18 og opefter · Mænd · Opdateret 2. okt. 2026 · NCT05568719ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
- Western New York BloodCare, Buffalo
- Northwell Health Hemostasis and Thrombosis Center at Long Island Jewish and Cohen Children's Medical Center, Hyde Park
- Weill Cornell Medical College - New York Presbyterian Hospital, New York
- og 2 flere
RekruttererObservationsstudie
Alle aldre · Alle køn · Opdateret 17. aug. 2026 · NCT04398628Open-Label Extension Study of Marstacimab in Hemophilia Participants With or Without Inhibitors
- Northwell Health HTC, New Hyde Park
RekruttererFase 3
Alder 1 til 74 · Mænd · Opdateret 1. jul. 2026 · NCT05145127An Observational Cohort Study to Characterize the Effectiveness and Safety of HEMGENIX® in Patients With Hemophilia B
- American Thrombosis and Hemostasis Network, Rochester
RekruttererObservationsstudie
Alder 18 og opefter · Alle køn · Opdateret 19. feb. 2026 · NCT06008938SEVENFACT® for Bleeding Events in Hemophilia With Inhibitors
- Northwell Health, Long Island Jewish, New Hyde Park
RekruttererFase 4
Alder 12 til 100 · Alle køn · Opdateret 12. jan. 2026 · NCT04647227Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.